DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OMACETAXINE MEPESUCCINATE

« Back to Dashboard

All Clinical Trials for Omacetaxine Mepesuccinate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002574	Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia	Completed	National Cancer Institute (NCI)	Phase 2	1994-09-01	Phase II trial to study the effectiveness of homoharringtonine and interferon alfa in treating patients with chronic myelogenous leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Interferon alfa may interfere with the growth of cancer cells. Combining chemotherapy with interferon alfa may kill more cancer cells.
NCT00003239	Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia	Completed	National Cancer Institute (NCI)	Phase 2	1998-03-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy with cytarabine and homoharringtonine and biological therapy with interferon alfa in treating patients with chronic phase chronic myelogenous leukemia.
NCT00003239	Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia	Completed	M.D. Anderson Cancer Center	Phase 2	1998-03-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy with cytarabine and homoharringtonine and biological therapy with interferon alfa in treating patients with chronic phase chronic myelogenous leukemia.
NCT00003694	Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase	Completed	National Cancer Institute (NCI)	Phase 2	1999-03-01	Phase II trial to study the effectiveness of homoharringtonine plus low-dose cytarabine in treating patients who have newly diagnosed chronic phase chronic myelogenous leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.
NCT00006364	Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia	Completed	National Cancer Institute (NCI)	Phase 2	1999-11-01	Phase II trial to study the effectiveness of homoharringtonine in treating patients who have chronic phase chronic myelogenous leukemia. Drugs used in chemotherapy, such as homoharringtonine, work in different ways to stop cancer cells from dividing so they stop growing or die

Clinical Trial Conditions for Omacetaxine Mepesuccinate

Condition Name

Condition Name for Omacetaxine Mepesuccinate
Intervention	Trials
Chronic Myeloid Leukemia	3
Leukemia	2
Chronic Myelogenous Leukemia, BCR-ABL1 Positive	2
AML	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Omacetaxine Mepesuccinate
Intervention	Trials
Leukemia, Myeloid	9
Leukemia	9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive	8
Leukemia, Myeloid, Chronic-Phase	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Omacetaxine Mepesuccinate

Trials by Country

Trials by Country for Omacetaxine Mepesuccinate
Location	Trials
United States	30
France	3
India	2
Singapore	2
Canada	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Omacetaxine Mepesuccinate
Location	Trials
Texas	8
New York	4
Indiana	3
Massachusetts	3
Pennsylvania	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Omacetaxine Mepesuccinate

Clinical Trial Phase

Clinical Trial Phase for Omacetaxine Mepesuccinate
Clinical Trial Phase	Trials
Phase 2	10
Phase 1/Phase 2	2
Phase 1	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Omacetaxine Mepesuccinate
Clinical Trial Phase	Trials
Completed	8
Recruiting	3
Terminated	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Omacetaxine Mepesuccinate

Sponsor Name

Sponsor Name for Omacetaxine Mepesuccinate
Sponsor	Trials
National Cancer Institute (NCI)	5
ChemGenex Pharmaceuticals	4
Teva Branded Pharmaceutical Products, R&D Inc.	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Omacetaxine Mepesuccinate
Sponsor	Trials
Industry	11
Other	5
NIH	5

Export unavailable in trial.
Subscribe for complete access.